Last reviewed · How we verify
Segluromet film coated tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Segluromet film coated tablets (Segluromet film coated tablets) — Humanis Saglık Anonim Sirketi.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Segluromet film coated tablets TARGET | Segluromet film coated tablets | Humanis Saglık Anonim Sirketi | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Segluromet film coated tablets CI watch — RSS
- Segluromet film coated tablets CI watch — Atom
- Segluromet film coated tablets CI watch — JSON
- Segluromet film coated tablets alone — RSS
Cite this brief
Drug Landscape (2026). Segluromet film coated tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/segluromet-film-coated-tablets. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab